The success of Viagra initially sparked a period of growth for pharma, but recent shifts present a complicated picture for investors. Off-patent competitors are eroding revenue, and persistent legal battles add https://tiannajcnx166547.jts-blog.com/39808914/sildenafil-and-big-pharma-a-precarious-investment